Update on Laser Photochemotherapy: An Alternative for Cancer Treatment
dc.contributor.author | Paiva, Marcos Bandiera [UNIFESP] | |
dc.contributor.author | Joo, Jayne | |
dc.contributor.author | Abrahão, Márcio [UNIFESP] | |
dc.contributor.author | Ribeiro, Joao Carlos [UNIFESP] | |
dc.contributor.author | Cervantes, Onivaldo [UNIFESP] | |
dc.contributor.author | Sercarz, Joel A. | |
dc.contributor.institution | Univ Calif Los Angeles | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Univ Calif Davis | |
dc.date.accessioned | 2018-06-15T13:50:14Z | |
dc.date.available | 2018-06-15T13:50:14Z | |
dc.date.issued | 2011-10-01 | |
dc.description.abstract | Although major progress has been made in surgery, radiation, and chemotherapy for the treatment of malignancy during the last 20 years, there has been little improvement in the survival of patients with recurrent or advanced head and neck cancer. Because of the ease and accessibility for surgery and their loco-regional biological behavior, head and neck cancers serve as an ideal model to test combined laser energy delivered via interstitial fiberoptics and chemotherapeutic agents activated by photo-thermal energy as an alternative, less invasive treatment for cancer. A number of investigators have shown that anthracyclines and cisplatin are likely candidates for light or heat activation in cancer cells. Maximum tolerated dose followed by photochemical and thermal activation via laser fiberoptics can improve treatment by sensitizing tumor response. The higher intratumor drug levels compared to systemic drug administration along with laser activation should also reduce systemic toxicity. In this article the authors analyze the concept of combining anti-cancer drugs and laser therapy and review the clinical application. In summary, the literature available suggests photochemotherapy with currently approved drugs and lasers may soon become an attractive alternative for cancer treatment. | en |
dc.description.affiliation | Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Head & Neck Surg, Los Angeles, CA 90095 USA | |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Otolaryngol & Head & Neck Surg, Div Head & Neck Surg, Sao Paulo, Brazil | |
dc.description.affiliation | Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA | |
dc.description.affiliationUnifesp | Univ Fed Sao Paulo, Dept Otolaryngol & Head & Neck Surg, Div Head & Neck Surg, Sao Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Division of Head and Neck Surgery | |
dc.description.sponsorship | Jonsson Comprehensive Cancer | |
dc.description.sponsorship | David Geffen School of Medicine at UCLA, National Cancer Institute - NIH | |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa no Estado de Sao Paulo | |
dc.description.sponsorshipID | David Geffen School of Medicine at UCLA, National Cancer Institute - NIH: K22 CA13985-02 | |
dc.description.sponsorshipID | Fundacao de Amparo a Pesquisa no Estado de Sao Paulo: 08/54714-6 | |
dc.format.extent | 772-779 | |
dc.identifier | http://dx.doi.org/10.2174/187152011797378742 | |
dc.identifier.citation | Anti-cancer Agents In Medicinal Chemistry. Sharjah: Bentham Science Publ Ltd, v. 11, n. 8, p. 772-779, 2011. | |
dc.identifier.doi | 10.2174/187152011797378742 | |
dc.identifier.issn | 1871-5206 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/42591 | |
dc.identifier.wos | WOS:000298057800011 | |
dc.language.iso | eng | |
dc.publisher | Bentham Science Publ Ltd | |
dc.relation.ispartof | Anti-cancer Agents In Medicinal Chemistry | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | Photochemotherapy | en |
dc.subject | combined intratumor therapy | en |
dc.subject | cisplatin | en |
dc.subject | laser-induced thermal therapy | en |
dc.subject | lasers | en |
dc.title | Update on Laser Photochemotherapy: An Alternative for Cancer Treatment | en |
dc.type | info:eu-repo/semantics/article |